Sun Pharma receives DCGI approval for Molxvir® (Molnupiravir) in India
Q1 FY23 Financial Press Release
We are committed to ensure uninterrupted supply of medicines to support the Covid-19 pandemic response
The Sun Story
Watch the inspiring growth story of Sun – from humble beginnings in 1983 with just 2 employees and 5 psychiatry products to becoming the 4th largest global generic pharmaceutical company, selling over 2000 products in over 100 countries.